Published on 5 May 2024 on Simply Wall St. via Yahoo Finance
Earnings Beat: Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Just Beat Analyst Forecasts, And Analysts...
Investors in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) had a good week, as its shares rose 9.7% to close at US$34.54 following the release of its first-quarter results. Revenues of US$8.2m came in 2.2% below estimates, but statutory losses were well contained with a per-share loss of US$1.45 being some 12% smaller than what the analysts were predicting. Following the result, the analysts have updated their earnings model, and it would be good to know whether they think there's been a strong change in the company's prospects, or if it's business as usual. Readers will be glad to know we've aggregated the latest statutory forecasts to see whether the analysts have changed their mind on Agios Pharmaceuticals after the latest results.
See our latest analysis for Agios Pharmaceuticals
